Birgitte Volck
Directeur/Membre du Conseil chez SOLENO THERAPEUTICS, INC.
Fortune : 263 060 $ au 30/04/2024
Postes actifs de Birgitte Volck
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SOLENO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 10/06/2019 | - |
| Independent Dir/Board Member | 10/06/2019 | - | |
| NYKODE THERAPEUTICS | Directeur/Membre du Conseil | 05/05/2021 | - |
Historique de carrière de Birgitte Volck
Anciens postes connus de Birgitte Volck
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ASCENDIS PHARMA A/S | Directeur/Membre du Conseil | 01/05/2016 | 12/07/2021 |
| Directeur Technique/Scientifique/R&D | 12/07/2021 | 01/12/2023 | |
| Independent Dir/Board Member | 01/05/2016 | 12/07/2021 | |
| AVROBIO, INC. | Directeur Technique/Scientifique/R&D | 01/12/2018 | 01/10/2020 |
TFS Trial Form Support AB
 TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden. | Directeur/Membre du Conseil | 01/05/2016 | 01/01/2020 |
| GSK PLC | Directeur Technique/Scientifique/R&D | 01/06/2016 | 01/08/2018 |
| WILSON THERAPEUTICS AB | Directeur/Membre du Conseil | 22/05/2017 | 01/05/2018 |
| Independent Dir/Board Member | 22/05/2017 | 01/05/2018 | |
| SWEDISH ORPHAN BIOVITRUM AB | Directeur Technique/Scientifique/R&D | 01/08/2012 | 01/01/2016 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2007 | 01/07/2012 |
| ░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Formation de Birgitte Volck
| University of Copenhagen | Doctorate Degree |
Statistiques
Internationale
| Suède | 5 |
| Danemark | 5 |
| Etats-Unis | 4 |
Opérationnelle
| Director/Board Member | 6 |
| Chief Tech/Sci/R&D Officer | 5 |
| Independent Dir/Board Member | 3 |
Sectorielle
| Health Technology | 10 |
| Commercial Services | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 7 |
|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| ASCENDIS PHARMA A/S | Health Technology |
| GSK PLC | Health Technology |
| AMGEN INC. | Health Technology |
| AVROBIO, INC. | Health Technology |
| SOLENO THERAPEUTICS, INC. | Health Technology |
| NYKODE THERAPEUTICS | Health Technology |
| Entreprise privées | 5 |
|---|---|
TFS Trial Form Support AB
TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden. | Commercial Services |
| Genzyme Danmark | |
Pharmexa A/S
 Pharmexa A/S Pharmaceuticals: MajorHealth Technology Pharmexa A/S is a leading company in the field of active immunotherapy for the treatment of serious chronic diseases. Pharmexa's proprietary AutoVac(tm) technology platform is broadly applicable, but the company has focused its resources on a number of cancer forms and chronic inflammatory diseases, with research and development programs targeted towards breast cancer, rheumatoid arthritis and bone degeneration | Health Technology |
Wilson Therapeutics AB
 Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Wilson Therapeutics AB engages in the development of novel therapies for patients with rare copper-mediated disorders. The company was founded on April 25, 2012 and is headquartered in Stockholm, Sweden. | Health Technology |
TFS Trial Form Support International AB
 TFS Trial Form Support International AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support International AB provides clinical contract research services. It offers clinical development planning, regulatory affairs, medical informatics, study and site coordination, clinical data management, biostatistics, medical writing, and other functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lud, Sweden. | Commercial Services |
- Bourse
- Insiders
- Birgitte Volck
- Expérience
